Drug Royalties Cayman Fund II LP — Form D
Drug Royalties Cayman Fund II LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-12-07. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-12-07
- Form: D
- Accession: 0001723440-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-300241
Issuer
- Name: Drug Royalties Cayman Fund II LP
- CIK: 0001723440
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2017
- Address: 510 MADISON AVENUE, 21ST FLOOR, NEW YORK, NY, 10022
- Phone: 212-257-4750
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| PATRICK L KELLY | Executive Officer | NEW YORK, NY |
| JAMES THOMAS ROTHWELL | Executive Officer | NEW YORK, NY |
| Ross L Stevens | Executive Officer | — |
More